Lateral Neck Dissection for Well-Differentiated Thyroid Carcinoma: Is Prophylactic Level V Neck Dissection Necessary? A Retrospective Cohort Study.


Journal

Ear, nose, & throat journal
ISSN: 1942-7522
Titre abrégé: Ear Nose Throat J
Pays: United States
ID NLM: 7701817

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 26 6 2023
pubmed: 30 4 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

The presence of clinically detectable papillary thyroid carcinoma (PTC) metastases in the lateral neck is an indication for neck dissection (ND) and thyroidectomy. Although there is a consensus regarding the importance of therapeutic selective ND of involved levels II to IV in patients with clinically evident locoregional metastatic disease, the prognostic benefit of level V prophylactic ND remains debatable. All patients who underwent thyroidectomy with ND for metastatic PTC between 2006 and 2019 were included in a single-institution retrospective study. Preoperative characteristics at initial presentation, imaging workup, intraoperative findings, and the final histopathological reports were retrieved from the institutional database. A total of 189 patients with locally advanced PTC were identified, of whom 22 (11.6%) patients underwent therapeutic selective ND at levels II to IV together with level V dissection due to clinical involvement. Comparison of the patients who were operated on level V to those who were not revealed no significant difference. The disease recurrence rate was 20.1% throughout an average follow-up of 5.1±3.1 years. No significant differences in recurrence rate were found between patients who underwent and those who did not undergo level V ND (22.7% vs 19.8%, There were no significant associations between level V dissection and risk for recurrence. Recurrence at level V was rare (4/189 patients, 2.1%). Our study's findings suggest a low prophylactic benefit of an elective level V ND. Elective level V ND should not be done routinely when lateral ND is indicated but should rather be considered after careful evaluation in high-risk patients.

Identifiants

pubmed: 33915059
doi: 10.1177/01455613211003805
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP349-NP357

Auteurs

Narin N Carmel Neiderman (NNC)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Harel Baris (H)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Irit Duek (I)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Anton Warshavsky (A)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Barak Ringel (B)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Elena Izkhakov (E)

Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Gilad Horowitz (G)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Dan M Fliss (DM)

Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH